Literature DB >> 23915461

Words of wisdom: Re: Screening for prostate cancer: US Preventive Services Task Force recommendation statement.

Peter C Albertsen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23915461     DOI： 10.1016/j.eururo.2013.06.027

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  8 in total

1.  Living arrangement and colorectal cancer screening: updated USPSTF guidelines.

Authors:  Denys T Lau; James B Kirby
Journal:  Am J Public Health       Date:  2009-08-20       Impact factor: 9.308

2.  Comparison of prostate cancer diagnosis in patients receiving unrelated urological and non-urological cancer care.

Authors:  Anthony T Corcoran; Marc C Smaldone; Brian L Egleston; Jay Simhan; Serge Ginzburg; Todd M Morgan; John Walton; David Y T Chen; Rosalia Viterbo; Richard E Greenberg; Robert G Uzzo; Alexander Kutikov
Journal:  BJU Int       Date:  2013-07       Impact factor: 5.588

3.  Impact of Comorbidities on Prostate Cancer Stage at Diagnosis in Florida.

Authors:  Hong Xiao; Fei Tan; Pierre Goovaerts; Georges Adunlin; Askal Ayalew Ali; Clement K Gwede; Youjie Huang
Journal:  Am J Mens Health       Date:  2014-12-26

4.  African american primary care physicians' prostate cancer screening practices.

Authors:  Louie E Ross; Ingrid J Hall
Journal:  J Prim Care Community Health       Date:  2013-10-17

5.  A combined prognostic serum interleukin-8 and interleukin-6 classifier for stage 1 lung cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.

Authors:  Bríd M Ryan; Sharon R Pine; Anil K Chaturvedi; Neil Caporaso; Curtis C Harris
Journal:  J Thorac Oncol       Date:  2014-10       Impact factor: 15.609

6.  African American men's and women's perceptions of clinical trials research: focusing on prostate cancer among a high-risk population in the South.

Authors:  Otis L Owens; Dawnyéa D Jackson; Tracey L Thomas; Daniela B Friedman; James R Hébert
Journal:  J Health Care Poor Underserved       Date:  2013-11

7.  Serum fucosylated prostate-specific antigen (PSA) improves the differentiation of aggressive from non-aggressive prostate cancers.

Authors:  Qing Kay Li; Li Chen; Ming-Hui Ao; Joyce Hanching Chiu; Zhen Zhang; Hui Zhang; Daniel W Chan
Journal:  Theranostics       Date:  2015-01-01       Impact factor: 11.556

Review 8.  Advice About Screening for Prostate Cancer With Prostate-Specific Antigen.

Authors:  Gannel Jean-Pierre
Journal:  J Adv Pract Oncol       Date:  2017-09-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.